Ahmed M Alshehri Selected Research

Human Influenza (Influenza)

8/2022

Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed M Alshehri Research Topics

Disease

2	COVID-19 08/2022 - 06/2022
1	Diabetes Complications 01/2024
1	Infections 12/2023
1	Surgical Wound Infection 12/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Thyroid Diseases (Thyroid Disease) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Inflammation (Inflammations) 08/2022
1	Dermatitis 08/2022
1	Human Influenza (Influenza) 08/2022
1	Allergic Contact Dermatitis 08/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Insulinoma 01/2018
1	Premature Birth (Birth, Premature) 12/2017
1	Premature Obstetric Labor (Premature Labor) 12/2017

Drug/Important Bio-Agent (IBA)

1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	epimedin AIBA 08/2022
1	COVID-19 VaccinesIBA 08/2022
1	CollagenIBA 08/2022
1	DinitrofluorobenzeneIBA 08/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2022
1	VaccinesIBA 08/2022
1	anti-voltage-gated calcium channel autoantibodyIBA 01/2018
1	Calcium Channels (Calcium Channel)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Fibronectins (Fibronectin)IBA 12/2017

Therapy/Procedure

1	Polypharmacy 01/2024
1	Antibiotic Prophylaxis 12/2023
1	Continuity of Patient Care 01/2023
1	Length of Stay 06/2022